EA200400849A1 - Композиции смесей для младенцев, содержащие повышенные количества альфа-лактальбумина - Google Patents

Композиции смесей для младенцев, содержащие повышенные количества альфа-лактальбумина

Info

Publication number
EA200400849A1
EA200400849A1 EA200400849A EA200400849A EA200400849A1 EA 200400849 A1 EA200400849 A1 EA 200400849A1 EA 200400849 A EA200400849 A EA 200400849A EA 200400849 A EA200400849 A EA 200400849A EA 200400849 A1 EA200400849 A1 EA 200400849A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lactalbumin
alpha
fraction
babies
mixture compositions
Prior art date
Application number
EA200400849A
Other languages
English (en)
Other versions
EA007148B1 (ru
Inventor
Чарльз Фрэнсиз Кульман
Эрик Луис Лайен
Джон Райли Вебер
Дэниел Мартин О'Каллахан
Original Assignee
Уайт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23345331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200400849(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Уайт filed Critical Уайт
Publication of EA200400849A1 publication Critical patent/EA200400849A1/ru
Publication of EA007148B1 publication Critical patent/EA007148B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение касается композиции смеси для младенцев, содержащей фракцию молочной сыворотки, причем 40% или менее общего белка в указанной фракции составляет альфа-лактальбумин и более 8% общего белка в указанной сывороточной фракции представляет бета-лактоглобулин, при этом процент альфа-лактальбумина в указанной сывороточной фракции больше, чем процент бета-лактоглобулина в указанной сывороточной фракции.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400849A 2001-12-21 2002-12-18 Композиции смесей для младенцев, содержащие повышенные количества альфа-лактальбумина EA007148B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34325301P 2001-12-21 2001-12-21
PCT/US2002/040811 WO2003055322A1 (en) 2001-12-21 2002-12-18 Infant formula compositions comprising increased amounts of alpha-lactalbumin

Publications (2)

Publication Number Publication Date
EA200400849A1 true EA200400849A1 (ru) 2004-10-28
EA007148B1 EA007148B1 (ru) 2006-08-25

Family

ID=23345331

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400849A EA007148B1 (ru) 2001-12-21 2002-12-18 Композиции смесей для младенцев, содержащие повышенные количества альфа-лактальбумина

Country Status (29)

Country Link
US (1) US6913778B2 (ru)
EP (1) EP1455585B1 (ru)
JP (1) JP4317455B2 (ru)
KR (1) KR100955408B1 (ru)
CN (2) CN101427802B (ru)
AR (1) AR037909A1 (ru)
AT (1) ATE439044T1 (ru)
AU (1) AU2002357354B2 (ru)
BR (1) BR0215198A (ru)
CA (1) CA2471423C (ru)
CO (1) CO5590862A2 (ru)
CY (1) CY1109503T1 (ru)
DE (1) DE60233346D1 (ru)
DK (1) DK1455585T3 (ru)
EA (1) EA007148B1 (ru)
EC (1) ECSP045154A (ru)
ES (1) ES2329667T3 (ru)
HK (1) HK1065925A1 (ru)
IL (2) IL162244A0 (ru)
MX (1) MXPA04005887A (ru)
NO (1) NO20043108L (ru)
NZ (1) NZ534041A (ru)
PL (1) PL371379A1 (ru)
PT (1) PT1455585E (ru)
SG (1) SG169897A1 (ru)
TW (1) TWI301052B (ru)
UA (1) UA81903C2 (ru)
WO (1) WO2003055322A1 (ru)
ZA (1) ZA200405777B (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
BR0315152A (pt) * 2002-10-10 2005-08-16 Wyeth Corp Composição alimentìcia para lactantes contendo nucleotìdeos
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20080089981A1 (en) † 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
JP5322405B2 (ja) * 2007-06-07 2013-10-23 小林製薬株式会社 タンパク質含有組成物
US8586122B2 (en) * 2007-07-26 2013-11-19 Loders Croklaan Usa Llc Composition suitable for use in baking
EP2205240A1 (en) * 2007-10-02 2010-07-14 Ariel-University Research And Development Company, Ltd. Endocannabinoids for enhancing growth and development in infants
PL2282641T3 (pl) * 2008-04-29 2013-01-31 Dsm Ip Assets Bv Kompozycja zawierająca węglowodany i peptydy, które zawierają tryptofan
US8986773B2 (en) * 2008-04-29 2015-03-24 Dsm Ip Assets B.V. Process for the preparation of packaged heat-preserved aqueous drink comprising casein micelles and tryptophan-rich peptides, and product so obtained
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
PL2493325T3 (pl) * 2009-10-28 2021-06-28 Valio Ltd Wyrób zawierający białka serwatkowe i sposób jego wytwarzania
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
WO2012077076A1 (en) * 2010-12-08 2012-06-14 Holt Patrick G Treating or preventing sensitivity to milk allergens
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
WO2012092084A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Improved tolerance in a low calorie infant formula
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20140371173A1 (en) 2011-02-10 2014-12-18 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
FI123267B (fi) * 2011-02-18 2013-01-15 Valio Oy Juusto ja sen valmistus
WO2012147075A1 (en) * 2011-04-28 2012-11-01 Shemen Industries Ltd Vegetable based oil preparation for baked goods
MX2011007872A (es) 2011-07-26 2013-01-29 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
BR112014010953A2 (pt) * 2011-11-10 2017-12-05 Nestec Sa fórmulas infantis e seus usos
FI125332B (fi) * 2011-11-11 2015-08-31 Valio Oy Menetelmä maitotuotteen valmistamiseksi
CN102630803A (zh) * 2012-05-15 2012-08-15 东北农业大学 母乳化牛乳蛋白及其制备方法
MX2012010488A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Formula infantil para el optimo crecimiento, proteccion gastrointestinal y proteccion inmunologica de infantes.
MX2012010487A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
CN103027116A (zh) * 2012-12-04 2013-04-10 内蒙古伊利实业集团股份有限公司 一种有助于睡眠的奶粉及其制备方法
WO2015154262A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
PL3145334T3 (pl) * 2014-05-19 2020-06-01 N.V. Nutricia Formulacje dojelitowe dla przedwcześnie urodzonych niemowląt zawierające zoptymalizowane poziomy przyjmowania fenyloalaniny
US11596167B2 (en) 2014-05-19 2023-03-07 N.V. Nutricia Formulas comprising optimised amino acid profiles
CN104012657B (zh) * 2014-05-21 2016-04-13 澳优乳业（中国）有限公司 一种氨基酸母乳化婴幼儿配方奶粉及其制备方法
CN104522175A (zh) * 2014-12-29 2015-04-22 光明乳业股份有限公司 一种低敏婴儿配方奶粉的制备及检测方法
EP3355722A4 (en) * 2015-09-28 2019-03-13 Nestec S.A. SEX SPECIFIC SYNTHETIC NUTRIENT COMPOSITIONS AND NUTRIENT SYSTEMS COMPRISING SAME
US10039765B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10617700B1 (en) * 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10039805B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US11122833B1 (en) * 2016-02-26 2021-09-21 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
EP3338841A1 (en) * 2016-12-23 2018-06-27 Ferdinand Haschke Liquid human milk supplement
CN110545679A (zh) * 2017-05-03 2019-12-06 雀巢产品有限公司 乳清蛋白质提取物及其作为鞘磷脂源的用途
EP3709991A1 (en) * 2017-11-13 2020-09-23 Greg Hannon Dietary product
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2020126536A1 (en) 2018-12-21 2020-06-25 Societe Des Produits Nestle S.A. Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children
CN114401639A (zh) 2019-09-16 2022-04-26 雀巢产品有限公司 用钙强化的基于乳清的营养组合物
KR102536585B1 (ko) * 2020-08-04 2023-05-24 주식회사 엘지생활건강 액상 조제유 조성물
WO2022177965A1 (en) * 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
CN114568705B (zh) * 2022-03-22 2023-04-25 中国农业大学 一种有利于锌吸收的蛋白口服液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
CA1243887A (en) 1984-07-03 1988-11-01 Shuryo Nakai REDUCING .beta.-LACTOGLOBULIN CONTENT IN WHEY PROTEIN CONCENTRATES FOR INFANT FORMULA USE
DE3885459T2 (de) 1987-05-14 1994-03-24 Commw Scient Ind Res Org Molkeproteinfraktionen.
GB8723651D0 (en) 1987-10-08 1987-11-11 Express Foods Group Ltd Process for containing concentrates
US5436020A (en) 1990-02-19 1995-07-25 Meiji Milk Products Company Limited Method for producing a formulated milk for infants analogous to human milk
US5169666A (en) 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
JP2622789B2 (ja) 1992-02-18 1997-06-18 雪印乳業株式会社 ホエーからα−ラクトアルブミン含有量の高い画分を製造する方法及び該画分を含有せしめてなる母乳代替物または栄養組成物
DE69220374T2 (de) 1992-12-23 1998-01-15 Campina Melkunie Bv Verfahren zur Gewinnung von Alpha-Lactalbumin und Beta-Lactoglobulin aus einem Molkeproteinprodukt
US6312755B1 (en) * 1999-07-16 2001-11-06 Ampc Whey treatment process for achieving high concentration of α-lactalbumin
WO2002028194A1 (en) 2000-10-05 2002-04-11 New Zealand Dairy Board Process for recovering proteins from whey protein containing feedstocks

Also Published As

Publication number Publication date
US20030124237A1 (en) 2003-07-03
NZ534041A (en) 2005-09-30
PT1455585E (pt) 2009-10-26
DK1455585T3 (da) 2009-12-07
US6913778B2 (en) 2005-07-05
CN1646025A (zh) 2005-07-27
AU2002357354B2 (en) 2008-11-20
DE60233346D1 (de) 2009-09-24
IL162244A (en) 2010-02-17
CA2471423C (en) 2012-02-21
SG169897A1 (en) 2011-04-29
UA81903C2 (ru) 2008-02-25
CN101427802B (zh) 2012-08-01
JP4317455B2 (ja) 2009-08-19
ECSP045154A (es) 2004-07-23
ZA200405777B (en) 2007-12-27
MXPA04005887A (es) 2004-09-13
WO2003055322A1 (en) 2003-07-10
ATE439044T1 (de) 2009-08-15
PL371379A1 (en) 2005-06-13
EA007148B1 (ru) 2006-08-25
BR0215198A (pt) 2004-11-16
NO20043108L (no) 2004-09-06
CA2471423A1 (en) 2003-07-10
KR100955408B1 (ko) 2010-05-06
JP2005514017A (ja) 2005-05-19
IL162244A0 (en) 2005-11-20
CN101427802A (zh) 2009-05-13
AU2002357354A1 (en) 2003-07-15
KR20040078650A (ko) 2004-09-10
EP1455585A1 (en) 2004-09-15
CO5590862A2 (es) 2005-12-30
CN100456936C (zh) 2009-02-04
TWI301052B (en) 2008-09-21
CY1109503T1 (el) 2012-05-23
TW200305371A (en) 2003-11-01
ES2329667T3 (es) 2009-11-30
EP1455585B1 (en) 2009-08-12
HK1065925A1 (en) 2005-03-11
AR037909A1 (es) 2004-12-22

Similar Documents

Publication Publication Date Title
EA200400849A1 (ru) Композиции смесей для младенцев, содержащие повышенные количества альфа-лактальбумина
Fujimura et al. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein lb
MD1443F1 (en) Copolymer-1 fraction, process for preparation thereof and compositions on base thereof for cerebrospinal sclerosis treatment
EA200700213A1 (ru) Терапевтические композиции с нейротоксином ботулина
ES2174855T3 (es) Metodos diagnosticos y composiciones farmaceuticas que se basan en proteinas notch y acidos nucleicos.
DK1439759T3 (da) Canolaproteinisolatfunktionalitet II
AT500379B1 (de) Tau-proteine
BR0209312A (pt) Composição alimentìcia de isolado de proteìna de canola
ES2175462T3 (es) Composiciones cristalizables que comprenden un complejo del dominio de proteasa ns3 del virus de la hepatitis c/ns4a, y cristales asi obtenidos.
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
WO2005021579A3 (en) Epo mimetic peptides and fusion proteins
BR0107474A (pt) Preparação de proteìnas e permuteìnas desalergenizadas
BRPI0519626A2 (pt) mÉtodos para a reduÇço do teor de um ou mais contaminantes, do teor de proteÍna s em uma composiÇço, do teor de um ou mais contaminantes de proteÍna em um sobrenadante de cultura de cÉlula, do teor de proteÍna s em um sobrenadante de cultura de cÉlula, composiÇço compreendendo uma proteÍna dependente de vitamina k de interesse
BR0208207A (pt) Redução da imunogenicidade das proteìnas de fusão
BRPI0412241A (pt) formulação para medicamentos de proteìna sem adição de albumina de soro humano (hsa)
ATE163768T1 (de) Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
DK382786A (da) Overfladeaktivt rekombinant-alveolarprotein
FI904951A0 (fi) Vaevnadsplasminogenaktivatorderivat.
ES2045770T3 (es) Composicion comestible de proteinas del suero desnaturalizadas.
TR199802584T2 (xx) Denat�re proteinin aktive edilmesi i�in y�ntem.
DE69413711T2 (de) Neue therapeutische kohlenhydratmischungen zur verwendung bei prämenstruellem syndrom
BR0012693A (pt) Variante, de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
ATE356831T1 (de) Neuer galaninrezeptor
EP0515246A3 (fr) Compositions protéiques à textures onctueuse
ATE271054T1 (de) Herstellung von metallkomplexen von aminosäuren, hergestellt durch hydrolyse von sojaprotein

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title